Expression of sHLA-G in supernatants of individually cultured 46-h embryos: A potentially valuable indicator of 'embryo competency' and IVF outcome

Reproductive BioMedicine Online

Volumn 9, Issue 1, 2004, Pages 74-78

  Sher, Geoffrey ^a,b,d   Keskintepe, Levent ^a   Nouriani, Mory ^a   Roussev, Roumen ^c   Batzofin, Joel ^a  

^a Sher Institute for Reproductive Medicine   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c Millenova Laboratories   (United States)

^d NONE   (United States)

Author keywords

ICSI; Implantation; IVF; Pregnancy; sHLA G

Indexed keywords

BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CULTURE MEDIUM; ECHOGRAPHY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FETUS DEVELOPMENT; GEOMETRY; HUMAN; INCIDENCE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; OOCYTE; OUTCOMES RESEARCH; PREGNANCY; RETROSPECTIVE STUDY;

EID: 3242680658     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)62113-X     Document Type: Article

References (26)

1. Bamberger AM, Jenatschke S, Schulte HM et al. 2000 Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG-3 choriocarcinima cells. Journal of Clinical Endocrinology and Metabolism 85, 3932-3936.
2. Barr S, Poggi S, Keszler M 2003 Triplet morbidity and mortality in a large case series. Journal of Perinatology 23, 368-371.
3. Choudhury SR, Knapp LA 2001 Human reproductive failure II: immunogenetic and interacting factors. Human Reproduction Update 7, 135-160.
4. Christiansen OB, Ring M, Rosgaard A et al. 1999 Association between HLA-DR1 and -DR3 antigens and unexplained repeated miscarriage. Human Reproduction Update 5, 249-255.
5. Chu W, Fant ME, Geraghty DE, Hunt JS 1998 Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts. Human Immunology 59, 435-442.
6. Ellis SA, Palmer MS, McMichael AJ 1990 Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. Journal of Immunology 15, 731-735.
7. Fernandez N, Cooper J, Sprinks M et al. 1999 A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions. Human Reproduction Update 5, 234-248.
8. Fisch JD, Sher G, Adamowicz M, Keskintepe L 2003 The graduated embryo score predicts the outcome of assisted reproductive technologies better than a single day 3 evaluation and achieves results associated with blastocyst transfer from day 3 embryo transfer. Fertility and Sterility 80, 1352-1358.
9. Fournel S, Huc X, Aguerre-Girr M 2000 Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens 55, 510-518.
10. Fuzzi B, Rizzo R, Criscuoli L et al. 2002 HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. European Journal of Immunology 32, 311-315.
11. Gianaroli L, Magli MC, Munne S et al. 1997 Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? Human Reproduction 12, 1762-1767.
12. Huisman GJ, Alberda AT, Leerentveld RA et al. 1994 A comparison of in vitro fertilization results after embryo transfer after 2, 3, and 4 days of embryo culture. Fertility and Sterility 61, 970-971. Erratum in: Fertility and Sterility, 62, 210.
13. Jurisicova A, Casper RF, MacLusky NJ et al. 1996a HLA-G expression during preimplantation human embryo development. Proceedings of the National Academy Sciences of the USA 93, 161-165.
14. Jurisicova A, Casper RF, MacLusky NJ, Librach CL 1996b Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development. Fertility and Sterility 65, 997-1002.
15. Kanai T, Fujii T, Kozuma S et al. 2001 HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Molecular Human Reproduction 7, 195-200.
16. Makhseed M, Raghupathy R, Azizieh F et al. 1999. Mitogen-induced cytokine responses of maternal peripheral blood lymphocytes indicate a differential Th-type bias in normal pregnancy and pregnancy failure. American Journal of Reproductive Immunology 42, 273-281.
17. Mallet V, Fournel S, Schmitt C et al. 1999 Primary cultured human thymic epithelial cells express both membrane-bound and soluble HLA-G translated products. Journal of Reproductive Immunology 43, 225-234.
18. Margreiter M, Weghofer A, Kogosowski A et al. 2003 A prospective randomized multicenter study to evaluate the best day for embryo transfer: does the outcome justify prolonged embryo culture? Journal of Assisted Reproduction and Genetics 20, 91-94.
19. Menicucci A, Noci I, Fuzzi B et al. 1999 Non-classic sHLA class I in human oocyte culture medium. Human Immunology 160, 1054-1057.
20. Munne S 2003 Preimplantation genetic diagnosis and human implantation - a review. Placenta 24, S70-76.
21. Neumann PJ, Gharib SD, Weinstein MC 1994 The cost of a successful delivery with in vitro fertilization. New England Journal of Medicine 28, 239-243.
22. Ng ST, Chang TH, Wu TC 1999 Prediction of the rates of fertilization, cleavage, and pregnancy success by cumulus-coronal morphology in an in vitro fertilization program. Fertility and Sterility 72, 412-417.
23. Pehlivan T, Rubio C, Rodrigo L et al. 2003 Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reproductive BioMedicine Online 6, 232-237.
24. Richter KS, Harris DC, Daneshmand ST, Shapiro BS 2001 Quantitative grading of a human blastocyst: optimal inner cell mass size and shape. Fertility and Sterility 76, 1157-1167.
25. Roussev R, Keskintepe L, Coulam C et al. 2003 Soluble HLA-G (sHLA-G) in human embryo culture media: a useful marker for assessing embryo quality, and implantation potential for IVF. Fertility and Sterility 80 (suppl. 3), 12-13.
26. Salihu HM, Aliyu MH, Rouse DJ et al. 2003 Alexander GR. Potentially preventable excess mortality among higher-order multiples. Obstetrics and Gynecology 102, 679-684.